Device-Led Skin Tightening After 40: What the Evidence Shows and What It Does Not

Published 15 June 2026 · Updated 19 August 2026

Somewhere in your forties the arithmetic of skincare changes. Creams keep doing what creams do, which is work on the surface, while the changes bothering you are happening several millimetres below it. That is the point at which most people start looking at clinic devices, and it is also the point at which marketing gets loudest and least accurate.

This page sets out what the published evidence actually supports for microfocused ultrasound, radiofrequency microneedling and broadband light, how long those results last, who should not have them, and which of these treatments Med Yu Med performs. Some of what follows is less flattering to the devices than a clinic page usually is. That is deliberate. The patients who leave a course unhappy are usually the ones who booked it expecting a facelift.

What actually changes in the skin after 40

Ageing skin is not one process. Collagen atrophy is described as a major factor in a 2007 review in Menopause International, PMID 17540135, which also reports a strong correlation between skin collagen loss and oestrogen deficiency due to the menopause. The same review notes that facial ageing is associated with a progressive increase in extensibility and a reduction in elasticity, and that skin becomes more fragile and slower to heal.

A 2021 review in Dermatology and Therapy, PMID 33242128, sets out what the oestrogen-deficient state does at tissue level: loss of collagen and elastin, reduced fibroblast function, reduced vascularity, and increased matrix metalloproteinase activity, producing dryness, wrinkles, atrophy and impaired barrier function.

Two consequences follow, and they matter before you choose a device. Skin that is thinner and slower to heal has less margin for aggressive treatment. And a device that works by stimulating fibroblasts is asking a cell population that is already less efficient to do more work, which is one reason results in this age group are usually gradual rather than dramatic.

The collagen figure everyone quotes, and where it actually comes from

You will see a version of this line on nearly every clinic site: collagen falls by about one per cent a year from your mid-twenties, and you have lost thirty per cent of it by your mid-forties. It is worth knowing what the underlying research says, because the popular version has drifted a long way from it.

The measurements come from a series of studies by Brincat and colleagues in the mid-1980s. A 1987 study in Obstetrics and Gynecology, PMID 3120067, measured skin collagen content, skin thickness, metacarpal index and forearm bone mineral content in postmenopausal women, and reported a similar decline of between one and two per cent per year after the menopause. A 1985 study in the British Journal of Obstetrics and Gynaecology, PMID 3978054, adds the detail that gets dropped: skin collagen content declined in relation to menopausal age but not to chronological age. A related 1987 paper, PMID 3828252, measured thigh skin rather than facial skin.

So the honest version is narrower than the marketed one. The rate applies to the years after menopause rather than to every year from your mid-twenties, the studies were conducted in postmenopausal women, and some of the measurements come from thigh skin. The direction of travel is real and well documented. The tidy percentage attached to a birthday is not.

Two of those papers compared treated and untreated women. In PMID 3978054 both skin collagen content and thickness were significantly greater in the women on sex hormone implants, and in PMID 3828252 the decline in thigh skin collagen was preventable in the treated group. The 2007 review adds that oestrogen use after the menopause increases collagen content, dermal thickness and elasticity, and calls for large-scale trials before any recommendation is made on that point. Hormone therapy is prescription-only, it is prescribed for menopausal indications after an individual risk assessment, and it is never prescribed for skin ageing. That is a discussion with a physician who manages menopause. Med Yu Med does not prescribe it or advise on it.

Microfocused ultrasound, and what the pooled data shows

Microfocused ultrasound heats small volumes of tissue at a set depth, creating microcoagulative zones that trigger a wound-healing response. A 2016 review in Facial Plastic Surgery, PMID 27248024, describes it targeting the deep reticular dermis and the superficial musculoaponeurotic system, and notes that it increases neocollagenesis while avoiding much of the epidermal heating that causes trouble with other non-ablative devices.

The most useful numbers come from a 2023 systematic review in the International Journal of Environmental Research and Public Health, PMID 36674277. It screened 693 studies and included 16. Every included study involved female patients. Brow lift measured between 0.47 and 1.7 mm. Submental lift was measured as a reduction of 26 to 45 square millimetres on lateral photographs.

Read those figures carefully, because they are the honest scale of the effect. A brow lift of one millimetre is visible in a photograph and is not a facelift. The same review reports pooled investigator-assessed scores at day 90 in 337 patients, where 92 per cent showed improvement in tightening or wrinkle reduction. Patient-assessed scores in 81 patients were more restrained: improvements were described as mild, rising from 42 per cent at 90 days to 53 per cent at 360 days.

The 2016 review puts the ceiling plainly. Results are not equivalent to those of a rhytidectomy, which is the surgical facelift. Anyone describing an ultrasound device as a non-surgical facelift is describing something the literature does not support.

What that effect costs in tolerance is set out under risks below. The same systematic review records that the treatment was moderately painful and that adverse effects beyond transient redness occurred in about 2 per cent of cases.

How long the ultrasound result lasts

This is the question clinics answer least precisely, and there is a published answer.

A 2023 narrative review in the Journal of Cosmetic Dermatology, PMID 37128835, covering 11 original articles on microfocused ultrasound with visualisation, reports that around half of patients were rated much improved or very much improved at days 30 and 90, while most returned to baseline by day 360. The 2023 systematic review is blunter about the evidence itself: longer-term follow-up data are not available.

Two reviews of the same modality reach slightly different conclusions about durability, which is itself informative. Plan for a result measured in months rather than years, and treat any promise of a permanent lift as a sales claim rather than a clinical one.

Radiofrequency microneedling, and what it does differently

Radiofrequency microneedling delivers heat through fine insulated needles into the dermis, sparing the surface. A 2021 review of the modality, PMID 33577211, assessed 42 studies of adequate quality, of which 14 concerned rejuvenation. It reports that the technique can be used repeatedly and safely in individuals with darker skin phototypes, and that tissue remodelling continues to improve for at least six months after a course.

That safety finding assumes appropriate settings and an experienced operator. The same modality still carries a risk of post-inflammatory hyperpigmentation at phototypes IV to VI, which is why conservative settings and a pigment conversation come before a course rather than after a bad result.

That six-month window is the practical takeaway. Judging the result two weeks after a session tells you about swelling, not about collagen.

For the neck, a 2022 randomised study in the Journal of Cosmetic Dermatology, PMID 34214220, treated 20 patients with mild to moderate neck laxity across three sessions and measured dermal thickness with optical coherence tomography. One of the two arms also received platelet-rich plasma, which Med Yu Med performs as a separate service. Both arms showed statistically significant improvement across all parameters, the device-only arm included, and the authors state that whether adding platelet-rich plasma helps remains questionable. They describe insulated microneedle radiofrequency as safe and effective for mild to moderate neck laxity, in the population and settings they studied. Twenty patients is a small study, and mild to moderate laxity is the population it was tested in.

Broadband light, and what the Stanford pilot actually found

Broadband light gets described in clinic marketing as reversing ageing at the genetic level. There is a real study behind that claim, and it says something more specific.

The paper is a 2013 pilot study in the Journal of Investigative Dermatology, PMID 22931923, from a Stanford group. Using 3′-end sequencing, the researchers found that skin ageing was associated with significantly altered expression of 2,265 coding and non-coding RNAs, and that 1,293 of those became more similar to their expression level in youthful skin after broadband light treatment. Their conclusion is that broadband light treatment can restore the gene expression pattern of photoaged and intrinsically aged skin to resemble young skin.

The word the marketing drops is pilot. This was a small mechanistic study measuring gene expression, not a trial measuring how people looked years later, and the authors present it as a source of new targets for understanding skin ageing. It is a genuinely interesting finding. It is not evidence that annual light sessions keep a face young, and no study has shown that.

Broadband light is used for pigment and vascular concerns, which is why it appears on this page at all. Med Yu Med performs it as BBL phototherapy.

The trade-off belongs in the same paragraph rather than in a footer. Treated pigment darkens first and forms a fine crust that flakes away over several days, redness follows a session, and protective eyewear is fitted before the light is fired. The clinic’s own service page rules the treatment out on recently sun-exposed or actively tanned skin, in pregnancy, and while taking photosensitising medication such as isotretinoin or some antibiotics, and it treats melasma as a case-by-case decision because light can make it worse.

Why broadband light needs a different conversation if your skin is darker

Broadband light works by targeting chromophores, the pigment and blood that absorb light in the skin. That is the operating principle of the device class rather than a finding from any single study. If your own skin has more melanin in it, your skin is competing with the target.

That risk is set out in full in the separate page on aesthetic treatments for Middle Eastern and darker skin types, which covers why devices that aim at pigment behave differently in Fitzpatrick types IV to VI, and why test spots stop being optional at those phototypes.

The short version for this page: at phototype IV and above, a pigment-targeting device is a decision that needs a test spot and a conversation about post-inflammatory hyperpigmentation before it is booked.

Combining devices, and where the evidence for sequencing runs out

Clinics like to present a sequence, usually resurfacing first, then dermal remodelling, then deep tightening. The logic is reasonable. The evidence for the specific order is thinner than the confidence with which it is presented.

A 2015 review in the Journal of Cosmetic and Laser Therapy, PMID 25260050, examined 15 studies of combination treatments and concluded that same-day combined treatments for rejuvenation are safe and improve clinical results without loss of efficacy. That is useful, and it comes with a limitation worth naming. All fifteen studies paired a device with an injectable, seven with fillers and eight with botulinum toxin, and the clinic performs both sides of that pairing. The published work on combining device with device is much smaller.

So a sensible plan spaces treatments, tracks what each one contributed, and does not stack three modalities in one afternoon because a package priced it that way.

What this clinic offers

Med Yu Med works on two tracks. The device list is set out below. On the injectable side the clinic performs botulinum therapy, hyaluronic acid lip filler, mesotherapy, biorevitalization with hyaluronic acid, amino acids and PDRN, collagen stimulator therapy, and PRP prepared from the patient’s own blood. That matters for this page: several of the studies quoted above paired a device with an injectable, and those pairings describe treatments available here rather than background reading. Which track fits a given concern, and in what order, is decided at consultation rather than picked from a price list.

The available treatments are Ultraformer MPT for microfocused ultrasound; Morpheus8, Genius by Lutronic and Vivace for radiofrequency microneedling; VOLNEWMER for monopolar radiofrequency; BBL phototherapy for pigment and vascular concerns; Fotona for laser work; and INDIBA, Endospheres and HELEO Pro LED at lower intensity.

Endolift belongs in a category of its own and should not be read alongside the surface devices above. The clinic’s service page describes it as a minimally invasive laser lift in which optical microfibres are threaded under the skin through tiny entry points under local anaesthetic, and it sets the expectation of mild swelling, bruising and tenderness for a few days afterwards. Anything that goes under the skin carries a different risk profile from anything that works on top of it, and it is assessed at its own consultation.

Two more of the treatments above carry conditions worth knowing before a consultation. Monopolar radiofrequency is ruled out on the clinic’s own page in pregnancy and breastfeeding, under the age of 18, with implanted electronic devices including pacemakers, and with metal implants or permanent fillers in the treatment area unless the doctor approves them. Laser work is ruled out in pregnancy and breastfeeding, on recently sun-exposed or tanned skin, on photosensitising medication, and over an active infection or herpes outbreak, and the more aggressive resurfacing modes produce redness, swelling and flaking for several days, much like sunburn that peels.

One caveat about the ultrasound evidence and the device in this clinic. The narrative review cited above, PMID 37128835, covers microfocused ultrasound with visualisation specifically, and applying those results to any other ultrasound platform is an extrapolation. The mechanism is shared. The specific numbers belong to the devices and settings used in those studies.

What a first consultation should cover

A consultation that produces a package price without a risk conversation has not been a consultation. Expect the clinician to cover the following.

• What is actually bothering you, described in terms of laxity, texture, pigment or volume rather than as a general wish to look fresher.
• Your Fitzpatrick phototype, which changes which devices are reasonable.
• The degree of laxity, since the systematic review found results declined as laxity increased.
• Your medical history, including autoimmune conditions, implanted electronic devices, recent isotretinoin and any photosensitising medication.
• What each proposed device does, and which layer it works on.
• When the result should be assessed, which is months rather than days.
• What happens if the result is disappointing, and whether that is included.

Questions worth asking before you buy a course

Five questions are worth asking out loud before you pay for anything.

What result should I expect at three months, expressed in something more concrete than a percentage improvement? How long has that result lasted in patients like me, and what does the published follow-up data show? What is the plan when it fades? How many of these treatments has this specific operator performed on this specific device? And which parts of the proposal are supported by studies on this device, rather than on the category in general?

Watch for answers that keep returning to how popular the treatment is instead of to what it did in patients like you.

Risks, and who should postpone

None of these treatments is surgery. Endolift still breaks the skin surface, and radiofrequency microneedling passes fine needles through it. Non-surgical is not the same as risk-free.

The 2023 systematic review of microfocused ultrasound reports that treatment was moderately painful and caused transient erythema with or without oedema, and that other adverse effects occurred in about 2 per cent of cases. Those included dysesthesia, meaning numbness or hypersensitivity, along with bruising, stinging, mandibular burns, striations and contact dermatitis. The narrative review adds a burn caused by improper application of the probe, and reports that no serious adverse events occurred across the studies it covered.

Radiofrequency microneedling commonly causes redness, swelling and tenderness for a few days, and in darker phototypes carries a risk of post-inflammatory hyperpigmentation that has to be managed with settings and aftercare.

The systematic review names two relative contraindications for microfocused ultrasound specifically.

• Excessive skin laxity, because positive results declined as laxity increased.
• A body mass index above 30, for the same reason.

Postpone or discuss carefully in these situations.

• Pregnancy or breastfeeding.
• An active infection, inflammatory flare or open lesion in the treatment area.
• Recent oral isotretinoin.
• An implanted electronic device, which is relevant to radiofrequency treatments.
• Tanned skin, or current use of a photosensitising medication, before any light-based treatment.
• A history of keloid scarring.

Each of these is a conversation with the treating physician rather than a rule to apply yourself.

What the evidence does not settle

Three gaps are worth stating, because they change what a reasonable expectation looks like.

Durability is the largest. The systematic review states that longer-term follow-up data are not available for microfocused ultrasound, and the narrative review found most patients back at baseline by one year. Anyone quoting a two-year or three-year result is quoting something the literature does not contain.

Protocols are not standardised. The systematic review notes that various device settings, treatment protocols and energies were applied across the included studies, which means a published outcome belongs to those parameters rather than to the device category.

Men are barely studied. Every study included in that systematic review involved female patients, and the authors specifically call for future work on male patients. If you are a man considering these treatments, the evidence base was not built on you.

When this needs a doctor now

Most reactions after these treatments are mild and settle within days. Some are not.

Call 998 immediately and do not wait for any of these: difficulty breathing, swelling of the lips, tongue or throat, chest pain, fainting or loss of consciousness.

Seek medical attention the same day for any of these.

• A blister, burn or open wound in the treated area.
• Numbness or asymmetry of facial movement that does not resolve within hours.
• Spreading redness with heat and pain, which can indicate infection.
• Fever after a procedure.
• A raised scar that continues to grow weeks after treatment.

In a medical emergency in the UAE, call 998.

Medically reviewed by

DR. Ilias Ildarovich Dautov

General Practitioner, Aesthetic Medicine Doctor, Dermatologist

DHA License No. 09620692-002